Brian Hilberdink

Brian Hilberdink has an extensive background in the pharmaceutical industry, with experience at companies such as Novo Nordisk and LEO Pharma. At Novo Nordisk, Brian held various senior leadership positions, including President of Novo Nordisk Canada Inc. and Senior Vice President of the Diabetes Business Unit. Brian played a crucial role in developing and executing commercial strategies, leading sales teams, and driving significant business growth. In March 2022, Brian joined LEO Pharma as the Executive Vice President and President of LEO Pharma Inc. (US), where Brian oversees the US operations and is a member of the Global Executive Team. With a strong track record of success and leadership in the healthcare sector, Brian Hilberdink is a valuable asset to any organization.